衡阳招聘

The ABAC program consists of the policies, procedures, systems and controls that GSK is required to implement and maintain in order to demonstrate compliance with international and Chinese local anti-bribery legislation. This role will support the business with implementation of the ABAC program across pan-China, including training, communications, trend analysis, risk assessments and benchmarking to ensure the continued adequacy and effectiveness of the ABAC program. It will also liaise with the Global ABAC team in keeping up to date on the programme and sharing of best practices.

Key Accountabilities/Responsibilities：

· Manage ABAC implementation by providing ongoing support across BUs, managing end to end process and maintaining DD tracker to ensure ABAC framework applied and executed across all China BUs

· Support business in performing risk assessment and due diligence of all third parties

· Develop ABAC training system and deliver different levels of trainings covering senior, mid-level and junior GSK employees across BUs

· Develop and maintain tools and templates to assess, track and control ABAC risks

· Collect and analyze data and develop metrics to measure and reflect the effectiveness of the ABAC program execution

· Drive consistency, efficiency and operational effectiveness of the ABAC program and make sure the liaison with ABAC CoE

· Develop and perform monitoring of ABAC activities and controls

Qualifications/Requirements:

· Bachelor degree and above

· 5 years experience in the Pharmaceutical Industry preferred

· Recognized professional accounting/auditing (e.g. ACA, ACCA, CPA or CIMA) or Legal qualification preferred

· Knowledge and understanding of UK anti-bribery laws, US FCPA and related global anti-bribery and corruption laws and regulations.

· Ability to assess/analyze complex information, understand its impact and make recommendations on appropriate action.

· High degree of organizational awareness; demonstrated ability to develop solutions to complex problems.

· Ability to identify emerging trends in bribery and corruption, by maintaining detailed knowledge of the internal and external business and risk environment.

· Strong interpersonal skills with excellent written and oral communication skills, including presentations to large and small audiences and senior executives.

· Proficient in English

GlaxoSmithkline/葛兰素史克
作为世界领先的制药业巨擘，葛兰素史克公司秉承以研究开发为基础的一贯理念，凭藉公司本身的技术潜力和资源优势，在当今瞬息万变的医疗保健领域保持强劲的增长势头。
葛兰素史克公司，由葛兰素威康和史克必成强强联合，于2000年12月成立。两家公司的历史均可追溯至19世纪中叶，各自在一个多世纪的不断创新和数次合并中，在医药领域都确立了世界级的领先地位。两个制药巨人的成功合并，为葛兰素史克成为行业中无可争议的领导者奠定了基础，并在全球药品市场中占据有7%的份额。
葛兰素史克公司总部设在英国，以美国为业务营运中心，在抗感染、中枢神经系统、呼吸和胃肠道/代谢四大医疗领域代表当今世界的最高水平，在疫苗领域雄居行业榜首。此外，公司在消费保健领域也居世界领先地位，主要产品包括非处方药、口腔护理品和营养保健饮料。2006年公司在全球的销售总额达232亿英镑。目前，公司在全球拥有10万余名既掌握专业技能又有奉献精神的出色员工。
全球研发中心有1万6千科学家和技术人员分布在全球许多国家。为进一步推动研发全球化，葛兰素史克(GSK)中国研发中心于2007年6月成立。中心将侧重于神经退行性病变的研究，目标是为多发性硬化病、帕金森病和阿尔茨海默氏病等严重疾病开发新药。中国研发中心将发展成有1000多科学家和技术人员的全球研发中心。中心将以科学研究为基础（science-driven），通过生物学，化学以及最新技术，创新开发新的治疗手段。中国研发中心将最终引领GSK在这一领域从识别药物靶标到后期临床研究的全球研发活动，并在中国和其他研究机构密切合作。GSK中国研发中心计划在未来10年内成长为GSK的大型研发中心之一。
更多信息请访问我们的网站：www.gsk.com or www.gskchina.com